Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Headache Pain
Hoofdauteurs: Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Milan 2018
Onderwerpen:
Consensus Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://ncbi.nlm.nih.gov/pubmed/30259200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items